NIH
Renewed Focus on Rapid SARS-CoV-2 Testing Has Dx Stakeholders Concerned About Meeting Demand
Premium
After the federal government's investments into rapid and at-home testing, there are concerns whether manufacturers can meet demand.
RADx Issues $77.7M in New Contracts for SARS-CoV-2 Rapid Diagnostic Tests
The awards support the development, validation, scale-up, and manufacturing of the tests with the goal of bringing them to market as early as this year.
Kephera Diagnostics Wins $300K NIH Grant for Chagas Disease Test
The test will be designed in both laboratory-based and point-of-care formats to address the needs of clinical and field settings.
Developed by researchers at the National Institutes of Health, the method could reduce the cost of sample prep by a factor of eight.
Fresh Off $4M NIH Grant, Vibrent Health Using Digital Health to Screen and Test for COVID-19
Premium
The firm is working with NIH on improving infectious disease detection, preparedness, and monitoring across the US.
Apr 16, 2021
Feb 4, 2021